Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

22.32 -1.07 (-4.57%)
Streaming Delayed Price Updated: 3:40 PM EDT, Apr 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Kenvue Inc. Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Can Kenvue Be a Reliable Dividend Stock to Hold for the Long Haul?
Kenvue's operations are diverse, boasting many strong brands. Is that enough to make this a solid dividend stock to own? 
Via The Motley Fool
Meta's Plans, Cyberattacks, and the EV Race
And we've got a look at two stocks worth watching: Chevron and Burford Capital. 
Via The Motley Fool
SNY Stock Sinks 15% as Sanofi Plans Consumer Unit Spinoff
The happy talk in Sanofi's press release didn't help with analysts, who have been disappointed in the company and SNY stock all year. 
Via InvestorPlace
The Best Blue Chip Dividend Stocks For Young Investors
Several economic factors, such as high inflation and rising interest rates, leave investors feeling skittish. For young investors, dividend stocks provide upside potential, portfolio stability, and... 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Check Out What Whales Are Doing With KVUE
Via Benzinga
Peering Into Kenvue's Recent Short Interest
Via Benzinga
Check Out What Whales Are Doing With KVUE
Via Benzinga
Price Over Earnings Overview: Kenvue
Via Benzinga
Kenvue (KVUE) Q3 2023 Earnings Call Transcript
KVUE earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
2 Exceptional Dividend Stocks Near 52-Week Lows. Are They Bargains Now?
Attractive valuation metrics don't always tell the whole story. 
Via The Motley Fool
The Best Stocks to Invest $5,000 In Right Now
Today, the following three healthcare players look like fantastic bargains. 
Via The Motley Fool
Down in the Double Digits, These 2 Classic Warren Buffett Stocks Make Great Buys Now
These players could deliver top returns over the long haul. 
Via The Motley Fool
3 Foundational Blue Chip Dow Dividend Stocks for Building Generational Wealth
Dow stocks can provide the confidence needed to hold through periods of volatility. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
These 2 Dow Stocks Moved Markets This Week
Bulls and bears alike looked closely at these two companies. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
(KVUE) - Analyzing Kenvue's Short Interest
Via Benzinga
Analyst Ratings for Kenvue
Via Benzinga
7 Healthcare Stocks That Can Cure a Lackluster Portfolio
Take a position in these companies' stocks to achieve long-term gains and give a jolt to your investment portfolio. 
Via InvestorPlace
Is Johnson & Johnson Still a Good Dividend Stock to Buy?
Investors wonder if the healthcare giant can keep raising its payout now that it no longer sells the consumer health brands that made it famous. 
Via The Motley Fool
Why Johnson & Johnson Stock Flopped Today
Perhaps those third-quarter results weren't as impressive as they first appeared to be. 
Via The Motley Fool
Is the "New" Johnson & Johnson Stock a Buy With Its Improved Profit Outlook?
Some things are different about J&J. But other things remain the same as they've been for a long time. 
Via The Motley Fool
Johnson & Johnson's Sharper Focus Is Already Paying Dividends for Investors
The healthcare behemoth reported strong earnings after separating its consumer health division. 
Via The Motley Fool
Johnson & Johnson Raises Outlook As The Health Care Bellwether Beats Views
The company beat third-quarter forecasts and raised its outlook for the year. It's now focusing on innovative drugs and medtech following its consumer health spinoff. 
Via Investor's Business Daily
New Johnson & Johnson's Q3 Earnings Beat Street View, Raises Annual Outlook
Johnson & Johnson (NYSE: JNJ) has reported Q3 FY23 adjusted earnings of $2.66 per share, up 19.3% Y/Y and beating the conse 
Via Benzinga
Topics Earnings
Exposures Financial
4 Dividend Stocks Yielding 4% or More to Buy Without Hesitation
These stocks offer attractive payouts that should rise in the future. 
Via The Motley Fool
Johnson & Johnson Stock: Is Now the Time to Sell?
Conservative investors buy Johnson & Johnson for the dividend, but that payout is less safe after its Kenvue spinoff 
Via InvestorPlace
7 High-Growth S&P 500 Stocks to Buy Now
Although industry stalwarts don’t typically offer robust profitability potential, these high-growth S&P 500 stocks might change your tune. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Birkenstock To Emerge After $1.6 Billion IPO For Polarizing Sandal Maker
Sometimes derided as ugly, Birkenstock "footbed" sandals continue to grow in popularity. 
Via Investor's Business Daily
Topics Initial Public Offering
Exposures Securities Market
2 Magnificent Dividend Kings to Buy Now
These stocks offer you income no matter what the market is doing. 
Via The Motley Fool
Most Active Equity Options For Midday - Wednesday, Oct. 4
Via Talk Markets
Here's Why Kenvue Stock Is (Slightly) Riskier Than It Seems
It's not about to crash, but eventually, it might struggle to thrive. 
Via The Motley Fool
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.